Komori
Nagase & (8012) · InitiativeAdvanced

Updating Investment Guidelines and Establishing an M&A Framework

First written in FY2017. 14 of 15 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2026.

15entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018-Q2 – FY20262017: 220172018: 320182019: 320192020: 020202021: 020212022: 220222023: 220232024: 020242025: 220252026: 12026
Same theme, other companies
Continued pursuit of strategic M&A for growthA theme 40 companies write about · 0 as a headwind · 40 as a tailwind

25 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 40 companies compared. The sentences above are computed from all 40.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「The Company acquired the high-purity chemicals business for semiconductor applications in Asia operated by US-based SACHEM, now the Nagase Circular Group, and opened a new plant for the recovery and recycling of semiconductor manufacturing chemicals (TMAH).」

    The acquisition of SACHEM's Asian business was completed under the M&A execution structure, and the Company proceeded through the opening of a new plant for the TMAH recovery and recycling business.
  2. FY2026-H1AdvancedAnnual report

    「In connection with the acquisition of interests, Seikem Japan Holding Godo Kaisha, Seikem Japan Godo Kaisha and Wuxi Sanka High Purity Chemical Co., Ltd. were included in the scope of consolidation. In connection with the acquisition of shares, SACHEM Korea Ltd. was included in the scope of consolidation.」

    Under its M&A execution structure, the Company advanced multiple acquisition projects, primarily in the electronics and energy fields, through their inclusion in the scope of consolidation.
  3. FY2025AdvancedAnnual report

    「The Company also decided to acquire the Asian business of US-based Sachem and established a new plant to expand its tetramethylammonium hydroxide (hereinafter, TMAH) recovery and recycling business. In the life sciences field, the Company decided to acquire, among other assets, the diagnostic reagents business of Asahi Kasei Pharma Corporation, with the businesses scheduled to become part of the Group on 1 July 2025.」

    M&A and growth investment projects took concrete shape, including the acquisition of Sachem's Asian semiconductor business, the decision to acquire, among other assets, Asahi Kasei Pharma's diagnostic reagents business, and the establishment of a new plant.
  4. FY2024-Q1AdvancedAnnual report

    「Flavor Tec - Aromas de Frutas Ltda (as an equity interest was acquired on 28 June 2023); Fruttini Sucos de Frutas Ltda (as an equity interest was acquired on 28 June 2023)」

    As a specific M&A and investment initiative, the Company acquired interests in Flavor Tec and Fruttini on 28 June 2023.
  5. FY2023AdvancedAnnual report

    「We built a plant in Salt Lake City, Utah, as a new base for the contract manufacturing business for sports nutrition products and commenced production.」

    As part of its M&A and growth investments, the Company established a new contract manufacturing facility for the Prinova Group and brought it through to the start of production.
  6. FY2022AdvancedAnnual report

    「In its food-related business, the Company acquired The Ingredient House, LLC, a distributor specializing in sweeteners, through the Prinova Group to expand its product offerings and business areas, and made investments to increase manufacturing capacity in its contract manufacturing business, thereby further strengthening its earnings base.」

    Through the Prinova Group's acquisition of The Ingredient House and investment to expand contract manufacturing capacity, the Company advanced food-related M&A and expanded its business platform.
  7. FY2022-Q3AdvancedAnnual report

    「During the third quarter of the consolidated fiscal year under review, The Ingredient House, LLC and Lakeshore Technologies, LLC were included within the scope of consolidation following the acquisition of equity interests.」

    As a specific M&A initiative, the Company acquired interests in 2 companies in the Lifestyle-related segment and made them consolidated subsidiaries.
  8. FY2020-Q2AdvancedAnnual report

    「The procedure for acquiring the interest in Prinova Group, LLC under the interest transfer agreement was completed on 6 August 2019.」

    The acquisition procedure for Prinova Group, LLC, for which the agreement was signed in FY2019, was completed, and a voting rights ratio of 93.3%, acquisition consideration of US$422 million and goodwill of US$335 million were provisionally recognized.
  9. FY2020-Q1AdvancedAnnual report

    「The procedure for acquiring the interest in Prinova Group, LLC under the interest transfer agreement was completed on 6 August 2019.」

    The procedure for acquiring the interest in Prinova Group, LLC, for which the agreement was signed in FY2019, was completed on 6 August 2019. The Company positioned Prinova Group, LLC as a strategic platform for expanding its food ingredients business in Europe and the Americas and indicated a policy of expanding the Group's regional presence together with Hayashibara's food ingredients business.
  10. FY2019AdvancedAnnual report

    「At a meeting of the Board of Directors held on 3 June 2019, the Company resolved that Nagase Holdings America Corporation, its wholly owned subsidiary established on 1 April 2019, would acquire an interest in Prinova Group, LLC, making Prinova Group, LLC and its subsidiaries consolidated subsidiaries, and entered into an interest transfer agreement on the same date.」

    Following the establishment of its M&A execution structure, the Company entered into an acquisition agreement for Prinova Group, LLC, which operates in food ingredients and other products, based on a voting rights ratio of 93.6% and an enterprise value of US$621 million.
  11. FY2019-Q2AdvancedAnnual report

    「Sales from the US distributor acquired during the second quarter of the previous consolidated fiscal year were reflected for the entire first-half cumulative period of the current consolidated fiscal year, resulting in higher sales overall.」

    For the US distributor acquired in the second quarter of FY2018, sales were reflected for the entire first-half cumulative period in the current fiscal year, indicating progress in capturing the acquisition benefits.
  12. FY2018AdvancedAnnual report

    「During the fiscal year, the Company acquired US specialty-chemical distributor Fitz Chem Corporation, now Fitz Chem LLC, and is carrying out a locally led PMI process while enhancing its regional headquarters functions.」

    After establishing the M&A execution framework, the Company completed the acquisition of Fitz Chem and advanced through locally led PMI.
  13. FY2018-Q3AdvancedAnnual report

    「The Functional Chemicals business reported a substantial increase in sales overall, as sales of coating materials and urethane materials increased due to steady automobile production in Japan and overseas, in addition to higher sales following the acquisition of a US distributor.」

    The acquisition of a US distributor was cited as a specific result after the M&A execution framework was established, contributing to higher sales in the Functional Chemicals business.
  14. FY2018-Q2AdvancedAnnual report

    「During the second quarter of the current fiscal year, 大泰化工株式会社 and Fitz Chem LLC were included in the scope of consolidation following the acquisition of shares.」

    The acquisition of shares in 2 companies and their addition to the scope of consolidation were cited as specific investments executed after the M&A execution framework was established.
  15. FY2017First statedAnnual report

    「During the fiscal year, to improve the quality of investments, the Company updated its investment guidelines, selected priority portfolio companies for monitoring and sought to strengthen its KPI monitoring framework. It also established the cross-functional M&A Promotion Project Team to support transactions and conduct company-wide awareness activities.」

    The new investment-management measures included updating the investment guidelines, selecting priority portfolio companies for monitoring, strengthening KPI monitoring and establishing the M&A Promotion Project Team.
Moved together

"Portfolio Optimization Across 4 Areas and Investment in Priority Areas" moved the same way as this thread, in the same document, in 10 of its 15 moves.

1088766★123456
  1. ★This thread
  2. 1Portfolio Optimization Across 4 Areas and Investment in Priority Areas10×
  3. 2Expanding Overseas Sales and Strengthening the Manufacturing Business’s Earnings Base8×
  4. 3Exclusion of 2 Affiliates from the Scope of Consolidation and the Equity Method Following the Sale of Their Shares8×
  5. 4Balancing ¥100 billion in growth investment with financial strength and stable dividends7×
  6. 5Transforming the Corporate Culture and Embedding the Mindset6×
  7. 6Talent Development and Use of Specialists and External Talent6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nagase & yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.